Daniel G Eramian - Net Worth and Insider Trading
Daniel G Eramian Net Worth
The estimated net worth of Daniel G Eramian is at least $322,104 dollars as of 2024-12-14. Daniel G Eramian is the EVP, Corporate Communications of CTI BioPharma Corp and owns about 35,435 shares of CTI BioPharma Corp (CTIC) stock worth over $322,104. Details can be seen in Daniel G Eramian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel G Eramian has not made any transactions after 2012-09-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel G Eramian
Daniel G Eramian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel G Eramian owns 1 companies in total, including CTI BioPharma Corp (CTIC) .
Click here to see the complete history of Daniel G Eramian’s form 4 insider trades.
Insider Ownership Summary of Daniel G Eramian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2012-09-20 | EVP & Corporate Communications |
Daniel G Eramian Latest Holdings Summary
Daniel G Eramian currently owns a total of 1 stock. Daniel G Eramian owns 35,435 shares of CTI BioPharma Corp (CTIC) as of September 20, 2012, with a value of $322,104.
Latest Holdings of Daniel G Eramian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2012-09-20 | 35,435 | 9.09 | 322,104 |
Holding Weightings of Daniel G Eramian
Daniel G Eramian Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel G Eramian has made a total of 0 transactions in CTI BioPharma Corp (CTIC) over the past 5 years. The most-recent trade in CTI BioPharma Corp is the sale of 1,500 shares on September 20, 2012, which brought Daniel G Eramian around $40,200.
Insider Trading History of Daniel G Eramian
- 1
Daniel G Eramian Trading Performance
Daniel G Eramian Ownership Network
Ownership Network List of Daniel G Eramian
Ownership Network Relation of Daniel G Eramian
Daniel G Eramian Owned Company Details
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Daniel G Eramian is the EVP & Corporate Communications of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
Daniel G Eramian Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel G Eramian. You might contact Daniel G Eramian via mailing address: 501 Elliott Ave. W., Suite #400, Seattle Wa 98119.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
